March 22nd 2023
Recent papers highlight possible role of inflammation in connections between COVID-19, cancer markers.
January 31st 2023
Prioritize Paxlovid for Unvaccinated Patients at High Risk of Severe COVID-19: Cost-effectiveness AnalysisJanuary 14th 2023
A new analysis has determined the cost-effectiveness of nirmatrelvir/ritonavir (Paxlovid), granted emergency use authorization by the FDA, across various scenarios of vaccination status and risk for severe disease.
What We're Reading: NYC Nursing Strike Ends; Hospital Volunteers and Labor Laws; Most Long COVID Symptoms EaseJanuary 12th 2023
Nurses in New York City reach agreement and end strike; hospitals benefiting from volunteer staff may be breaking labor laws; most lingering COVID symptoms will heal on its own, study finds.
What We’re Reading: Biden to Extend PHE Once More; High Court Rejects Pharma Suits; 988 Calls SoarJanuary 10th 2023
President Joe Biden expected to renew COVID-19 public health emergency (PHE) one more time; Bristol Myers Squibb and Pfizer are denied by the Supreme Court; funding for the 988 mental health helpline expands inclusivity efforts.
What We’re Reading: SC, ID Courts Rule on Abortion; NIH Pilots COVID-19 Program; ADHD Drug Shortages RiseJanuary 6th 2023
State courts in South Carolina and Idaho ruled in opposite ways on abortion bans; virtual COVID-19 diagnostic and treatment launches in community; generic methylphenidate medication shortages negatively impact ADHD treatment.
Top 5 Most-Read COVID-19 News of 2022December 22nd 2022
2022's most-read news about the pandemic included the impact of COVID-19 on patients with asthma, the Biden administration's plans to advance vaccination and other initiatives, information about when SARS-CoV-2 is at its most infectious, and more.
Impact of COVID-19 Seen in 2021 National Health Care Expenditures ReportDecember 14th 2022
The effects of the COVID-19 pandemic were clear in the US national health care expenditure analysis of spending last year, as federal spending dropped, but health care use rebounded in 2021.
What We’re Reading: ACA Marketplace Enrollment Rises; Vaccine Sharing Initiative May End; Tracking Opioid OverdosesDecember 8th 2022
Approximately 5.5 million people have enrolled in health care coverage through the Affordable Care Act (ACA) marketplace for 2023; the Gavi alliance is debating the end of the worldwide vaccine sharing initiative; the White House is now tracking nonfatal opioid overdoses.
Nirmatrelvir-Ritonavir Shows Safety, Efficacy in Real-world Study of High-risk COVID-19 PatientsNovember 23rd 2022
The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen.
What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent TrialNovember 10th 2022
A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.
What We’re Reading: VA to Prioritize Cancer Claims; Pfizer’s COVID-19 Cash; Medicaid Coverage ConcernsNovember 8th 2022
The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.
Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022July 6th 2022
COVID-19 was ranked in the top 5 diagnoses through telehealth in the Midwest, Northeast, and West regions as well as nationally in the month of April, coinciding with an increase in COVID-19 cases.
What’s Next in Health Care? Panelists Highlight Data, Partnerships Post-COVID-19June 24th 2022
Panelists of an AHIP 2022 session discussed how future policy, infrastructure, and investment strategies in public health will reinforce the efforts already made during the pandemic, with partnerships and engagement key to optimize innovation.
Contributor: COVID-19 Falls Out of Top 5 Telehealth Diagnoses in February 2022May 9th 2022
The February drop out of the top 5 coincided with a sharp decline in new cases of COVID-19, as reported by the CDC, following the January peak of the wave of cases related to the Omicron variant.
Telehealth at Minnesota Oncology: Tackling COVID-19, Educating Patients, and Overcoming the WeatherFebruary 14th 2022
Rajini Katipamula-Malisetti, MD, a medical oncologist and hematologist with Minnesota Oncology who practices in Coon Rapids, has seen telehealth’s usefulness up close. During a pandemic, it can increase the number of touch points in areas such as survivorship care and nutrition, which would otherwise require a separate visit to the office.
Study Supports Pfizer, Moderna COVID-19 Vaccines’ Safety in Patients With Multiple MyelomaJanuary 26th 2022
Study results showed that both the Pfizer-BioNTech and Moderna COVID-19 vaccines were safe and effective in patients with multiple myeloma, which investigators hope will improve vaccine hesitancy in the high-risk population.
Telehealth User Experiences During COVID-19: A Case Study of Outpatient Cardiovascular Clinics Affiliated With a Large Academic Practice
In cardiovascular clinics during COVID-19, notable barriers to successful telehealth use included obtaining diagnostic information needed to deliver high-quality care and technology-related challenges for patients.
To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez SaysNovember 7th 2021
While low- and middle-income countries remain desperate for a COVID-19 vaccine, the United States has entered a dangerous new phase of the pandemic, where antivaccine forces are exporting their antiscience beliefs to other countries, according to a keynote speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Efficacy of COVID-19 Vaccines in Real-World Settings Even Better Than Expected, Fauci SaysMay 16th 2021
Anthony Fauci, MD, told attendees at the ATS 2021 International Conference that the real-world evidence of vaccines against SARS-CoV-2, the virus that causes COVID-19, is even better than expected.
What We're Reading: Pfizer Vaccine Lessens Hospitalization, Death Risk; 6M Doses Delayed; Mental Health in Coronavirus SurvivorsFebruary 22nd 2021
Pfizer/BioNTech vaccine shown to prevent most coronavirus disease 2019 (COVID-19)–related deaths or hospitalizations; extreme weather delays 6 million vaccine doses; post-traumatic stress disorder and anxiety seen in COVID-19 survivors.